Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).
Provided is a method for producing a non-colored polyester with a high molecular weight. The method is to produce a polyester represented by a general formula (2). This method comprises: a first step of heating, under the presence of an antimony catalyst, a compound represented by the general formula (1) at a heating temperature in a range of from a melting point of the compound to a temperature that is 10°C higher than the melting point; and a second step of heating a solid product or viscous product obtained after the first step at a heating temperature in a range of from the melting point of the compound represented by the general formula (1) to 270°C. In the general formula (1), Z represents a divalent hydrocarbon group having 1 to 12 carbon atoms; R1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a phenyl group; R2 represents a methyl group or an ethyl group; and m represents an integer of 0 to 2. In the general formula (2), Z, R2 and m are defined as above in the general formula (1), and n represents an average repeating unit number satisfying n=10 to 600.
Provided is a method for producing a non-colored polyester with a high molecular weight. The method is to produce a polyester represented by a general formula (2). This method comprises: a first step of heating, under the presence of an antimony catalyst, a compound represented by the general formula (1) at a heating temperature in a range of from a melting point of the compound to a temperature that is 10° C. higher than the melting point; and a second step of heating a solid product or viscous product obtained after the first step at a heating temperature in a range of from the melting point of the compound represented by the general formula (1) to 270° C.
Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).
Copolymerization of lactones and bioaromatics via concurrent ring-opening polymerization/polycondensation
作者:Ha Thi Hoang Nguyen、Gabriel N. Short、Pengxu Qi、Stephen A. Miller
DOI:10.1039/c6gc03238a
日期:——
Concurrent ring-openingpolymerization/polycondensation of lactones and bioaromatic hydroxy-acids yields random copolymers with improved and controlled thermal properties.